Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Associate Commissioner Linda Suydam to coordinate FDAMA compliance plan.

This article was originally published in The Tan Sheet

Executive Summary

FDA ASSOCIATE COMMISSIONER SUYDAM TO COORDINATE FDAMA COMPLIANCE plan drafting mandated in the FDA Modernization Act. Former acting Deputy Commissioner for Operations Linda Suydam returns to the agency July 6 in the newly created position of associate commissioner for strategic management. Her first task will be gathering constituent input for the compliance plan, which is due in November on the one-year anniversary of FDAMA. FDA plans to convene public meetings over the summer to solicit input on the agency's strategic direction to prepare the report.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088586

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel